The Sync Project said it’s partnered with Berklee College of Music’s Institute for Creative Entrepreneurship as it explores the therapeutic effects of music.
The groups plan to collaborate on original research, joint course development and an internship program, according to the Sync Project, which is backed by PureTech. The 1st step in the partnership will be a new course at Berklee, "Music as Medicine," during the 2015-2016 academic year, according to the company.
The course is slated to focus on recent advances in the neuroscience of music and the use of music as medicine.
“Music can be a catalyst for new disruptive ideas to emerge, whether those ideas are applied to the creative music space or whether those ideas are exported into other fields, like health. The Sync Project’s rigorous focus on the leading science of the neurological and health impacts of music, makes them a perfect partner,” Berklee Institute’s Panos Panay said in prepared remarks.
The Sync Project aims to build a platform to scientifically measure music and its effect on human health, designed to map music characteristics to real-time biometrics to enable the large-scale study of the therapeutic effects of music.
“The Sync Project’s mission is to bring together the scientists, technologists, clinicians and musicians of the world to help accelerate the discovery of the clinical applications of music. With this collaboration, we hope to engage and inspire the next generation of musicians to help us advance the field of music as medicine,” PureTech CEO and Sync Project co-founder Daphne Zohar said.
Earlier today PureTech filed for a $160 million initial public offering on the London Stock Exchange.
